Enlivex Therapeutics Ltd.

NasdaqCM:ENLV Stock Report

Market Cap: US$33.0m

Enlivex Therapeutics Ltd. Company Information

Enlivex Therapeutics Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: Enlivex Therapeutics Ltd.
  • Ticker: ENLV
  • Exchange: NasdaqCM
  • Founded: NaN
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$32.996m
  • Shares Outstanding: 20.88m
  • Website: https://www.enlivex.com

Number of Employees

Location

  • Enlivex Therapeutics Ltd.
  • 14 Einstein Street
  • Ness Ziona
  • 7403618
  • Israel

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ENLVNasdaqCM (Nasdaq Capital Market)YesOrdinary SharesUSUSDMar 2019
1BTDB (Deutsche Boerse AG)YesOrdinary SharesDEEURMar 2019
ENLVTASE (The Tel-Aviv Stock Exchange)YesOrdinary SharesILILSMar 2019

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/09/27 05:40
End of Day Share Price 2024/09/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.